Established in 2011, VF Bioscience is a French biotech company developing innovative, high-quality functional ingredients for dietary supplements and functional food. We have a strict commitment to quality and efficacy; all our products are research-based and clinically validated.
Our research focuses on the identification of new probiotic strains, active bacterial metabolites and fermentation products. Through strategic scientific and commercial partnerships, we have extended our product portfolio to selected, patented plant extracts.
Applications of VF Bioscience products include prevention of cardiovascular and metabolic disorders, immune support, improvement of mood and cognitive function, bone health maintenance... All ingredients are exclusive, designed to provide optimal support for health and wellbeing.
We are located in Lille, France, at the heart of a major European medical and academic cluster. Thanks to our collaborations with local universities and hospitals, we can perform preclinical and clinical studies to validate the properties of our innovative products.
Our Miami-based subsidiary, VF Bioscience USA, develops products for the North American market. These products are based on the same, exclusive lactic acid bacteria strains as the European products.
We know that the efficacy of a probiotic is highly dependent on the strain. This is why we only work with exclusive, fully characterised, clinically validated strains.
We currently offer Lactobacillus fermentum ME-3, a patented probiotic with unique antioxidant properties. Consumption of Lactobacillus fermentum ME-3 boosts production of the major cellular antioxidant glutathione. Twenty years of research and clinical studies support the efficacy of L.fermentum ME-3 for cardiovascular and metabolic disease prevention (reduction of oxidized LDL, cholesterol and triglycerides), anti-aging (systemic antioxidant effect) and detoxification (liver function support).
Other lactic acid bacteria strains are in the pipeline and will soon be available for use in dietary supplements, as well as for production of dairy products and functional foods.
VF Bioscience has established a commercial and scientific partnership with Amino Up Chemical Ltd, a Japanese company producing unique, clinically-validated plant extracts. VF Bioscience works as the exclusive European distributor of Amino Up's products, AHCC® and ETAS®.
VF Bioscience also offers ingredients developed by the Italian biotech company Active Botanicals Research (ABR, Brendola, Italy). ABR has developed an industrial platform for the production of selected active ingredients from suspension plant cell cultures. This approach offers multiple benefits: unlimited supply, even for rare plant species; perfect homogeneity from batch to batch, with no influence of seasonality; strictly controlled production environment that guarantees the absence of contaminants, pesticides or fertilisers in the final product.
Three products are already available: Teupol, teupolioside from Ajuga reptans (modulator of 5-alpha reductase, for testosterone-related disorders); Echinan, echinacoside from Echinacea angustifolia (immune support); and Acteos, verbascoside from Lippia citriodora (metabolic syndrome, antioxidant effect).